Literature DB >> 8390063

PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls.

J E Litton1, J Neiman, S Pauli, L Farde, T Hindmarsh, C Halldin, G Sedvall.   

Abstract

Benzodiazepine (BZ) receptor binding in the brain was determined in five chronic alcohol-dependent men and in five healthy male control subjects using [11C]flumazenil (Ro 15-1788) and positron emission tomography (PET). Magnetic resonance imaging was used to evaluate brain anatomy and pathology, and to define regions of interest in the brain. [11C]Flumazenil binding was quantified by applying a saturation procedure with two PET experiments, the first with high (400-3400 Ci/mmol) and the second with low (approximately 1 Ci/mmol) specific radioactivity. Radioactivity in the pons was taken as an estimate of free and nonspecifically bound radioligand. Equilibrium was defined to prevail when the derivative of specific binding (dCb(t)/dt) was equal to zero. The values were used in a Scatchard analysis for determination of the maximum density of binding sites (Bmax) and the equilibrium binding constant (Kd). The mean values of Bmax and Kd were about the same in the two groups, but the Bmax variance for the alcoholics was significantly greater for all regions of interest as compared with the healthy volunteers. The results may indicate that chronic alcohol consumption has multiple effects on the BZ receptor complex.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390063     DOI: 10.1016/0925-4927(93)90019-e

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

Review 1.  Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivity.

Authors:  Scott J Moeller; Edythe D London; Georg Northoff
Journal:  Neurosci Biobehav Rev       Date:  2015-12-01       Impact factor: 8.989

Review 2.  Traditional receptor theory and its application to neuroreceptor measurements in functional imaging.

Authors:  R W Kerwin; L S Pilowsky
Journal:  Eur J Nucl Med       Date:  1995-07

3.  Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).

Authors:  Charles M Laymon; Rajesh Narendran; Neale S Mason; Jonathan P Carney; Brian J Lopresti; Chester A Mathis; James M Mountz; Donald Sashin; W Gordan Frankle
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

Review 4.  Imaging receptor changes in human drug abusers.

Authors:  Kelly P Cosgrove
Journal:  Curr Top Behav Neurosci       Date:  2010

Review 5.  Neuronal cell death in Wernicke's encephalopathy: pathophysiologic mechanisms and implications for PET imaging.

Authors:  D K Leong; R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

6.  Differential effects of flumazenil in alcoholic and nonalcoholic cirrhotic patients.

Authors:  F Kapczinski; D Sherman; R Williams; M Lader; V Curran
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

Review 7.  Neuroimaging of reward mechanisms in Gambling disorder: an integrative review.

Authors:  Luke Clark; Isabelle Boileau; Martin Zack
Journal:  Mol Psychiatry       Date:  2018-09-13       Impact factor: 15.992

Review 8.  (18)F-fluorodeoxyglucose and (18)F-flumazenil positron emission tomography in patients with refractory epilepsy.

Authors:  Marina Hodolic; Raffi Topakian; Robert Pichler
Journal:  Radiol Oncol       Date:  2016-07-19       Impact factor: 2.991

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.